These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23107278)

  • 1. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
    Nielsen J; Kane JM; Correll CU
    Bipolar Disord; 2012 Dec; 14(8):863-9. PubMed ID: 23107278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
    Nielsen J; Nielsen RE; Correll CU
    J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study.
    Rohde C; Polcwiartek C; Correll CU; Nielsen J
    J Pers Disord; 2018 Dec; 32(6):823-837. PubMed ID: 29120277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study.
    Rohde C; Hilker R; Siskind D; Nielsen J
    J Psychopharmacol; 2018 Nov; 32(11):1197-1203. PubMed ID: 29944071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.
    Wu CS; Wang SC; Liu SK
    Bipolar Disord; 2015 Jun; 17(4):415-23. PubMed ID: 25295837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine for treatment-resistant bipolar disorder: a systematic review.
    Li XB; Tang YL; Wang CY; de Leon J
    Bipolar Disord; 2015 May; 17(3):235-47. PubMed ID: 25346322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
    Carlson PJ; Merlock MC; Suppes T
    Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania.
    Suppes T; Ozcan ME; Carmody T
    Bipolar Disord; 2004 Aug; 6(4):329-32. PubMed ID: 15225152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clozapine on sleep in bipolar and schizoaffective disorders.
    Armitage R; Cole D; Suppes T; Ozcan ME
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1065-70. PubMed ID: 15610918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical and temporal variations in clozapine prescription for schizophrenia.
    Nielsen J; Røge R; Schjerning O; Sørensen HJ; Taylor D
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
    Miller S; Ittasakul P; Wang PW; Hill SJ; Childers ME; Rasgon N; Ketter TA
    J Clin Psychopharmacol; 2012 Dec; 32(6):814-9. PubMed ID: 23131875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
    Wheeler A; Humberstone V; Robinson G
    J Psychopharmacol; 2009 Nov; 23(8):957-65. PubMed ID: 18635713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is clozapine a mood stabilizer?
    Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
    J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.
    Beherec L; Lambrey S; Quilici G; Rosier A; Falissard B; Guillin O
    J Clin Psychopharmacol; 2011 Jun; 31(3):341-4. PubMed ID: 21508854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.